This course has expired. View available courses.
Women's Health
Current treatment for women experiencing menopausal symptoms
Menopausal hormone therapy (MHT) can make a significant difference to women experiencing symptoms of menopause. Vasomotor (hot flashes) and genitourinary (vaginal atrophy, genital dryness, burning, irritation, dyspareunia) are the most common symptoms, experienced by up to 80% of women. As many as 25% of these women will seek treatment. Systemic hormone therapy is the most […]
DURATION
0.5 hr
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2022-06-14
Menopausal hormone therapy (MHT) can make a significant difference to women experiencing symptoms of menopause. Vasomotor (hot flashes) and genitourinary (vaginal atrophy, genital dryness, burning, irritation, dyspareunia) are the most common symptoms, experienced by up to 80% of women. As many as 25% of these women will seek treatment. Systemic hormone therapy is the most effective treatment for most menopausal symptoms. Bone protection is also an indication for MHT even without vasomotor or other symptoms.
There are several considerations when determining whether treatment is appropriate, and which treatment to choose. Women with no contraindications who are experiencing menopausal symptoms that are impacting QoL may be considered for treatment with MHT. The benefit-risk ratio is most favorable when therapy is initiated with women within 10 years of the last period, and/or under 60 years of age.
This 30-minute accredited program focuses on systemic MHT. It addresses the assessment criteria to determine if a patient is a good candidate for MHT and reviews the current MHT options, reasons to consider switching treatment options, and counselling patients about management of MHT.
Know more by watching Canadian Experts discuss Tibolone in the context of other available tissue-specific estrogen compounds
This program has received an educational grant or in-kind support from BioSyent Pharma Inc.
Faculty
Denise Black, MD, FRCSC
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Susan Goldstein, MD, CCFP, FCFP, NCMP
Marla Shapiro, C.M. MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Select the appropriate patients for systemic menopausal hormone therapy (MHT);
- Review and differentiate between current MHT options;
- Discuss strategies when switching MHT options;
- Counsel patients about the management of MHT.